| human | Q5 |
| P6178 | Dimensions author ID | 0617410622.26 |
| P269 | IdRef ID | 13119786X |
| P244 | Library of Congress authority ID | n2014192261 |
| P496 | ORCID iD | 0000-0002-4081-6464 |
| P1153 | Scopus author ID | 56967560800 |
| P10861 | Springer Nature person ID | 0617410622.26 |
| P214 | VIAF ID | 211335759 |
| P69 | educated at | University of Melbourne | Q319078 |
| The Alfred Hospital | Q7713086 | ||
| P108 | employer | Columbia University | Q49088 |
| Northwell Health | Q7056650 | ||
| Albert Einstein College of Medicine | Q2030894 | ||
| P734 | family name | Davidson | Q13479473 |
| Davidson | Q13479473 | ||
| Davidson | Q13479473 | ||
| P735 | given name | Anne | Q564684 |
| Anne | Q564684 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q59032140 | A critical role of the liver in inducing oral tolerance to adenoviral vectors for long-term gene therapy |
| Q59032432 | A monoclonal anti-idiotype specific for human polyclonal IgM rheumatoid factor |
| Q43709939 | A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler-Najjar syndrome |
| Q38930224 | A systems approach to renal inflammation in SLE. |
| Q35174510 | A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis |
| Q90012316 | Accelerating Medicines Partnership: Organizational Structure and Preliminary Data From the Phase 1 Studies of Lupus Nephritis |
| Q59031590 | Activated Interstitial Macrophages are Important Mediators of SLE Nephritis |
| Q42725543 | Activated basophils give lupus a booster shot |
| Q59031453 | Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis |
| Q36985612 | Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis |
| Q77873054 | An aggressive form of polyarticular arthritis in a man with CD154 mutation (X-linked hyper-IgM syndrome) |
| Q37360351 | An in vitro assay for detection of glomerular binding IgG autoantibodies in patients with systemic lupus erythematosus |
| Q59030879 | Analysis of Renal Mononuclear Phagocytes in Murine Models of SLE |
| Q41837557 | Anti-tumor necrosis factor α treatment of interferon-α-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation |
| Q34325674 | Autoimmune diseases. |
| Q37012870 | Autoimmunity stimulated by adoptively transferred dendritic cells is initiated by both alphabeta and gammadelta T cells but does not require MyD88 signaling |
| Q42706248 | B cells twist and shout |
| Q36504641 | B-cell activating factor targeted therapy and lupus |
| Q59030599 | BAFF and APRIL and Their Receptors |
| Q37900758 | BAFF and selection of autoreactive B cells |
| Q28507214 | BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses |
| Q37211258 | BAFF blockade for systemic lupus erythematosus: will the promise be fulfilled? |
| Q90341652 | BAFF inhibition in SLE-Is tolerance restored? |
| Q37844764 | BAFF inhibition: a new class of drugs for the treatment of autoimmunity |
| Q35686772 | BAFF/APRIL inhibition decreases selection of naive but not antigen-induced autoreactive B cells in murine systemic lupus erythematosus |
| Q37593590 | BAFF: a local and systemic target in autoimmune diseases |
| Q47371480 | Bim suppresses the development of SLE by limiting myeloid inflammatory responses. |
| Q36088049 | Block and tackle: CTLA4Ig takes on lupus |
| Q59032739 | Bone crisis of Gaucher's disease due to bone ischemia: A case report |
| Q35128133 | CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus |
| Q33364310 | CTLA4Ig prevents initiation but not evolution of anti-phospholipid syndrome in NZW/BXSB mice |
| Q42225952 | Chlorpromazine-associated haemolysis in anorexia nervosa. |
| Q35119957 | Co-stimulatory blockade in the treatment of murine systemic lupus erythematosus (SLE). |
| Q35027749 | Comparative transcriptional profiling of 3 murine models of SLE nephritis reveals both unique and shared regulatory networks |
| Q40461845 | Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential. |
| Q36083938 | Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis |
| Q26796041 | Defects in Germinal Center Selection in SLE |
| Q41833307 | Editorial: autoimmunity to vimentin and lupus nephritis |
| Q33803763 | Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study |
| Q44305354 | Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus |
| Q41965925 | Enhanced selection of high affinity DNA-reactive B cells following cyclophosphamide treatment in mice |
| Q40400494 | Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice |
| Q59032408 | Expression of Rheumatoid Factor Idiotypes 17.109, 6b6.6 and 4c9 in the Sera of Pima Indians |
| Q59032809 | Faculty of 1000 evaluation for BAFF and MyD88 signals promote a lupuslike disease independent of T cells |
| Q59032831 | Faculty of 1000 evaluation for Bystander B cells rapidly acquire antigen receptors from activated B cells by membrane transfer |
| Q59032852 | Faculty of 1000 evaluation for Distinct cell-specific control of autoimmunity and infection by FcgammaRIIb |
| Q59032875 | Faculty of 1000 evaluation for Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4 |
| Q59032896 | Faculty of 1000 evaluation for Follicular shuttling of marginal zone B cells facilitates antigen transport |
| Q59032917 | Faculty of 1000 evaluation for Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist |
| Q59032938 | Faculty of 1000 evaluation for Mincle is an ITAM-coupled activating receptor that senses damaged cells |
| Q59032961 | Faculty of 1000 evaluation for Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation |
| Q59032983 | Faculty of 1000 evaluation for Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response program |
| Q59033006 | Faculty of 1000 evaluation for Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis |
| Q34549069 | Familial systemic lupus erythematosus. Presence of a cross-reactive idiotype in healthy family members |
| Q59031144 | Future advances in pharmacogenomics: BAFF, APRIL and plasma cells |
| Q59030649 | General Features of Autoimmune Disease |
| Q59031632 | General Features of Autoimmune Disease |
| Q34186905 | Generation and analysis of clonal IgM- and IgG-producing human B cell lines expressing an anti-DNA-associated idiotype |
| Q59032786 | HYDRALAZINE-INDUCED LUPUS: NO ASSOCIATION WITH HLA-DR4 |
| Q35118781 | IFN-α confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/W F1 mice |
| Q37210594 | IFNα Inducible Models of Murine SLE. |
| Q36010662 | Identification of stage-specific genes associated with lupus nephritis and response to remission induction in (NZB × NZW)F1 and NZM2410 mice. |
| Q46791449 | Identification of stage-specific genes associated with lupus nephritis and response to remission induction in NZB/W and NZM2410 mice. |
| Q59033027 | Idiotypes in Systemic Lupus Erythematosus |
| Q59032499 | Idiotypes in Systemic Lupus Erythematosus (Part 1 of 2) |
| Q59032525 | Idiotypes in Systemic Lupus Erythematosus (Part 2 of 2) |
| Q59032551 | Idiotypic analyses of anti-DNA antibodies in systemic lupus and monoclonal gammopathy |
| Q59032715 | IgG binding enhances DNAase I sensitivity of N-acetoxy-N-2-acetylaminofluorene-modified ΦX-174 RF DNA |
| Q58214877 | Induction of B7-1 in podocytes is associated with nephrotic syndrome |
| Q37361947 | Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats |
| Q53590084 | Inhibition of Helicobacter hepaticus-induced colitis by IL-10 requires the p50/p105 subunit of NF-kappa B. |
| Q42560878 | Inhibitory short synthetic oligodeoxynucleotides and lupus |
| Q36051171 | Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression |
| Q30410652 | Interferon alpha on NZM2328.Lc1R27: enhancing autoimmunity and immune complex-mediated glomerulonephritis without end stage renal failure |
| Q34462033 | Interferon-α accelerates murine systemic lupus erythematosus in a T cell-dependent manner |
| Q59030930 | Isolation of Dendritic Cells and Macrophages from the Murine Kidneys of Lupus by Cell Sorter |
| Q59032183 | Long term liver directed gene therapy by downregulating the anti adenovirus Th1 immune response |
| Q35045927 | Lowering anti-dsDNA antibodies--what's new? |
| Q33998360 | Lupus nephritis: lessons from murine models |
| Q37374861 | Lupus-specific antibodies reveal an altered pattern of somatic mutation |
| Q59031797 | Mechanism of Action of Transmembrane Activator and Calcium Modulator Ligand Interactor-Ig in Murine Systemic Lupus Erythematosus |
| Q43874081 | Mechanism of action of combined short-term CTLA4Ig and anti-CD40 ligand in murine systemic lupus erythematosus |
| Q59032248 | Mechanisms of intrathymic tolerance induction to isolated rat hepatocyte allografts |
| Q34250038 | Molecular characterization of a somatically mutated anti-DNA antibody bearing two systemic lupus erythematosus-related idiotypes |
| Q41401910 | Molecular characterization of monoclonal IgM derived from human B cell lines expressing the 4C9 rheumatoid factor associated idiotype |
| Q38588001 | Molecular studies of lupus nephritis kidneys |
| Q59031658 | New immune modulatory drugs for systemic lupus erythematosus—what can we expect? |
| Q59031501 | OR.14. IFNα Accelerates SLE in a T Cell Dependent and BAFF Independent Manner |
| Q59032675 | ORIGINS OF ANTI-DNA ANTIBODIES |
| Q37364744 | Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors |
| Q45887065 | Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenoviruses |
| Q59030347 | P39 SHARED AND ENDORGAN SPECIFIC TRANSCRIPTIONAL NETWORKS IN SKIN VERSUS KIDNEY BIOPSIES IN SYSTEMIC LUPUS |
| Q36560135 | Pathogenesis and treatment of systemic lupus erythematosus nephritis |
| Q59030730 | Pathogenetic Mechanisms in Lupus Nephritis |
| Q51723759 | Pathogenetic role of glomerular CXCL13 expression in lupus nephritis. |
| Q45938061 | Plasma cells in systemic lupus erythematosus: the long and short of it all. |
| Q59032160 | Prenatal tolerization to recombinant adenovirus permits long-term correction of bilirubin glucuronidation defect in Gunn rats by repeated adenovirus-mediated gene therapy |
| Q33380975 | Prevention of murine antiphospholipid syndrome by BAFF blockade |
| Q59030960 | Process and Analysis of Kidney Infiltrates by Flow Cytometry from Murine Lupus Nephritis |
| Q33733803 | Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages |
| Q43678686 | Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinoma |
| Q59032762 | Red cell ferritin content: a re-evaluation of indices for iron deficiency in the anaemia of rheumatoid arthritis |
| Q24608897 | Rheumatoid factors from the peripheral blood of two patients with rheumatoid arthritis are genetically heterogeneous and somatically mutated |
| Q42566796 | Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis in NZM2410 mice |
| Q59031863 | Short Term Administration of Costimulatory Blockade and Cyclophosphamide Induces Remission of Systemic Lupus Erythematosus Nephritis in NZB/W F1 Mice by a Mechanism Downstream of Renal Immune Complex Deposition |
| Q56903863 | Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition |
| Q59032207 | Somatic Mutation |
| Q46034338 | Speculation on the role of somatic mutation in the generation of anti-DNA antibodies. |
| Q35991361 | Structure and function of renal macrophages and dendritic cells from lupus-prone mice |
| Q35988718 | Sustaining the Rheumatology Research Enterprise |
| Q58908917 | Systemic lupus erythematosus |
| Q59032616 | THE CLINICAL SIGNIFICANCE OF THE ANTICENTROMERE ANTIBODY |
| Q35202579 | TLR7 influences germinal center selection in murine SLE. |
| Q36712941 | Taming lupus-a new understanding of pathogenesis is leading to clinical advances |
| Q37802627 | Targeting BAFF in autoimmunity |
| Q37060593 | Targeting of the immune system in systemic lupus erythematosus |
| Q59032593 | The Role Of Somatic Mutation Of Immunoglobulin Genes In Autoimmunity |
| Q59032103 | The Role of Variable Region Gene Rearrangements in the Generation of Autoantibodies |
| Q36339344 | The Yaa locus and IFN-α fine-tune germinal center B cell selection in murine systemic lupus erythematosus |
| Q37217047 | The effect of BAFF inhibition on autoreactive B cell selection in murine SLE. |
| Q52019966 | The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation. |
| Q34525244 | The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus |
| Q26827373 | The rationale for BAFF inhibition in systemic lupus erythematosus |
| Q59031429 | Tinea versicolor associated with etanercept therapy |
| Q45883731 | Transient immunosuppression with FK506 permits long-term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat. |
| Q36139902 | Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis |
| Q59032652 | Use of anti-idiotypic antibodies to explore genetic mechanisms of production of anti-DNA antibodies |
| Q36765221 | What is damaging the kidney in lupus nephritis? |
Search more.